Treatment Of Sciatica by Hijamah(cupping) therapy

Phase 2

Not yet recruiting

Conditions: Nerve root and plexus compressionsin diseases classified elsewhere,

Registration Number: CTRI/2019/05/018946

Lead Sponsor: Jamia Hamdard

Brief Summary: This proposed open, randomized, prospective clinical study will be conducted on the diagnosed patients of Sciatica according to defined inclusion and exclusion criteria. 30 patients in group A and 30 patients in group B will allocated randomly. Hijamah at Warik and Fakhiz will be done in group A patients, whereas Hijamah at Saaq and Kaab will be done in group B patients on Day 0, Day 14 and Day 28. The assessment will be done on 0 day, 14th day, 28th day and 42nd day for improvement in pain, disability and quality of life. This study will validate the efficacy of Hijamah therapy in the management of Sciatica and will compare the efficacy as per the sites of Hijamah.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

Already diagnosed patients of sciatica presenting with all or some of the following signs and symptoms Unilateral leg pain greater than low back pain radiating towards leg/ foot/toes Positive straight-leg-raising sign Numbness and/ or tingling sensation in the same distribution Pain intensity score of 30 -60 mm on a 100-mm visual analog scale (VAS) Willingness to accept wet cupping intervention.

Exclusion Criteria

Pregnant and lactating women.
Patients of previous back surgery/ lumbar spine surgery.
Patients of spinal tumors, gross/fixed developmental deformity, cauda equine or vertebral fracture Patients of bleeding disorders Patients of anaemia (Hb<10gm%) Patients taking any other conservative treatment for sciatica (NSAIDS, corticosteroids, physiotherapy, acupuncture etc.) Patients with malignancy or any liver, kidney or heart disease Patients of of inherited neuropathy or neuropathy attributable to other causes like hypothyroidism, vitamin B12 deficiency etc.
Motor weakness/Muscle wasting Patients suffering from Psychiatric disorders HIV/AIDS, HCV and HBsAg positive patients History of stroke, severe hypertension and uncontrolled diabetes mellitus Unwilling to participate in the study.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relief in pain due to sciatica	0 day, 42 day

Secondary Outcome Measures

Name	Time	Method
Improvement in Disability and Quality of life	0 day, 42 day

Trial Locations

Locations (1): Majeedia Unani Hospital
🇮🇳
South, DELHI, India
Majeedia Unani Hospital
🇮🇳South, DELHI, India
Dr Mohd Yaqoob
Principal investigator
9671610426
yaqoobmdunani@gmail.com